466 related articles for article (PubMed ID: 17040289)
21. Heat shock protein induced TCR gammadelta gene rearrangements in patients with oral cancer.
Wadia P; Atre N; Pradhan T; Mistry R; Chiplunkar S
Oral Oncol; 2005 Feb; 41(2):175-82. PubMed ID: 15695120
[TBL] [Abstract][Full Text] [Related]
22. Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient.
Roncella S; Cutrona G; Truini M; Airoldi I; Pezzolo A; Valetto A; Di Martino D; Dadati P; De Rossi A; Ulivi M; Fontana I; Nocera A; Valente U; Ferrarini M; Pistoia V
Haematologica; 2000 Mar; 85(3):256-62. PubMed ID: 10702813
[TBL] [Abstract][Full Text] [Related]
23. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
24. Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration.
Tamaska J; Adam E; Kozma A; Gopcsa L; Andrikovics H; Tordai A; Halm G; Bereczki L; Bagdi E; Krenacs L
Virchows Arch; 2006 Oct; 449(4):479-83. PubMed ID: 16941150
[TBL] [Abstract][Full Text] [Related]
25. Presence of clonal T-cell receptor gene rearrangements provides evidence of widespread intramucosal intestinal T-cell lymphoma.
Schmitt-Gräff A; Daum S; Hummel M; Zemlin M; Stein H; Riecken EO
Z Gastroenterol; 1996 Oct; 34(10):680-5. PubMed ID: 8921577
[TBL] [Abstract][Full Text] [Related]
26. Hepatosplenic γδ T-cell lymphoma: an overview.
Visnyei K; Grossbard ML; Shapira I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):360-9. PubMed ID: 23876844
[TBL] [Abstract][Full Text] [Related]
27. Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.
Gopcsa L; Bányai A; Tamáska J; Karádi A; Matolcsy A; Pálóczi K
Haematologia (Budap); 2002; 32(4):519-27. PubMed ID: 12803128
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of T-cell receptor gamma (TCRgamma) gene rearrangement on formalin-fixed, paraffin-embedded tissues by PCR assays.
Tai YC; Peh SC
Singapore Med J; 2003 May; 44(5):250-5. PubMed ID: 13677361
[TBL] [Abstract][Full Text] [Related]
29. Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
Camera A; Pezzullo L; Villa MR; Luciano L; Pane F; Izzo B; Boccuni P; Di Noto R; Del Vecchio L; Salvatore F; Rotoli B
Haematologica; 2000 May; 85(5):496-501. PubMed ID: 10800166
[TBL] [Abstract][Full Text] [Related]
30. A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8.
Jain H; Shetty D; Jain H; Sengar M; Khattry N; Subramanian PG
Cancer Genet; 2018 Dec; 228-229():17-20. PubMed ID: 30553467
[TBL] [Abstract][Full Text] [Related]
31. Hepatic cytotoxic T-cell infiltrates in patients with peripheral T-cell proliferative diseases/lymphomas: clinicopathological and molecular analysis.
Mitarnun W; Saechan V; Suwiwat S; Pradutkanchana J; Takao S; Ishida T
Pathol Int; 2004 Nov; 54(11):819-29. PubMed ID: 15533224
[TBL] [Abstract][Full Text] [Related]
32. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.
Steurer M; Stauder R; Grünewald K; Gunsilius E; Duba HC; Gastl G; Dirnhofer S
Hum Pathol; 2002 Feb; 33(2):253-8. PubMed ID: 11957154
[TBL] [Abstract][Full Text] [Related]
33. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
34. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.
Przybylski GK; Wu H; Macon WR; Finan J; Leonard DG; Felgar RE; DiGiuseppe JA; Nowell PC; Swerdlow SH; Kadin ME; Wasik MA; Salhany KE
J Mol Diagn; 2000 Feb; 2(1):11-9. PubMed ID: 11272897
[TBL] [Abstract][Full Text] [Related]
35. Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma.
Futagbi G; Welbeck JE; Tetteh JK; Hviid L; Akanmori BD
Malar J; 2007 May; 6():69. PubMed ID: 17521425
[TBL] [Abstract][Full Text] [Related]
36. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
[TBL] [Abstract][Full Text] [Related]
37. Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules.
Sadahira Y; Notohara K; Manabe T
J Clin Pathol; 2003 Aug; 56(8):631-3. PubMed ID: 12890821
[TBL] [Abstract][Full Text] [Related]
38. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation.
Gassas A; Kirby M; Weitzman S; Ngan B; Abla O; Doyle JJ
Am J Hematol; 2004 Feb; 75(2):113-4. PubMed ID: 14755380
[TBL] [Abstract][Full Text] [Related]
39. Hepatosplenic gamma delta T-cell lymphoma with a novel cytogenetic alteration and cerebrospinal fluid infiltration: biological and clinical features.
Ferrari D; Girmenia G; Migliorini L; Nosari A; Morra E
Haematologica; 2002 Mar; 87(3):ECR11. PubMed ID: 11869957
[No Abstract] [Full Text] [Related]
40. Cytogenetic and molecular characterization of a hepatosplenic T-cell lymphoma: report of a novel chromosomal aberration.
Mandava S; Sonar R; Ahmad F; Yadav AK; Chheda P; Ramani M; Gupta AD; Das BR
Cancer Genet; 2011 Feb; 204(2):103-7. PubMed ID: 21504708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
